Sungmin Woo1, Soleen Ghafoor2, Anton S Becker3, Hedvig Hricak3, Alvin C Goh4, Hebert Alberto Vargas3. 1. Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065. Electronic address: woos@mskcc.org. 2. Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland. 3. Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065. 4. Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
Abstract
BACKGROUND: Intradiverticular bladder tumors (IDBT) are rare but clinically important, as they are difficult to assess endoscopically due to limited anatomic access and risk of perforation. MRI may be helpful in assessing IDBT and providing relevant staging and prognostic information. PURPOSE: To assess MRI findings of IDBT and their relationship with overall survival. METHODS: This retrospective study included 31 consecutive patients with IDBT undergoing MRI from 2008 to 2018 identified through electronic medical records and PACS database search. Two radiologists independently assessed the following MRI features: size (>3 vs ≤3 cm), diverticular neck involvement, Vesical Imaging-Reporting and Data System (VI-RADS) score (>3 vs ≤3), perivesical fat infiltration, additional tumors and suspicious pelvic lymph nodes. Overall survival was estimated using Kaplan-Meier analysis; and the relationship with clinicopathological and MRI features was determined using the Cox proportional-hazards regression model. Inter-reader agreement was assessed using intraclass correlation coefficients (ICC) and Cohen's kappa (K). RESULTS: Median follow-up was 1044 days (interquartile range, 474-1952 days). Twenty-six (83.9%) patients underwent surgical treatment with or without neoadjuvant chemotherapy. On MRI, greater tumor size (>3 cm), diverticular neck involvement, perivesical extension, and suspicious lymph nodes were associated with lower overall survival (HR = 3.6-8.1 and 4.3-6.3 for the 2 radiologists, p ≤ 0.03). Other clinicopathological or MRI findings were not associated with survival (p = 0.27-0.65). Inter-reader agreement was excellent for tumor size (ICC = 0.991; 95% CI 0.982-0.996), fair for VI-RADS (K = 0.52, 95% CI, 0.22-0.82), and moderate for others (K = 0.61-0.79). CONCLUSION: In patients with IDBT, several MRI features were significantly associated with overall survival. Utilizing all available clinicopathological and imaging information may improve estimation of prognosis.
BACKGROUND: Intradiverticular bladder tumors (IDBT) are rare but clinically important, as they are difficult to assess endoscopically due to limited anatomic access and risk of perforation. MRI may be helpful in assessing IDBT and providing relevant staging and prognostic information. PURPOSE: To assess MRI findings of IDBT and their relationship with overall survival. METHODS: This retrospective study included 31 consecutive patients with IDBT undergoing MRI from 2008 to 2018 identified through electronic medical records and PACS database search. Two radiologists independently assessed the following MRI features: size (>3 vs ≤3 cm), diverticular neck involvement, Vesical Imaging-Reporting and Data System (VI-RADS) score (>3 vs ≤3), perivesical fat infiltration, additional tumors and suspicious pelvic lymph nodes. Overall survival was estimated using Kaplan-Meier analysis; and the relationship with clinicopathological and MRI features was determined using the Cox proportional-hazards regression model. Inter-reader agreement was assessed using intraclass correlation coefficients (ICC) and Cohen's kappa (K). RESULTS: Median follow-up was 1044 days (interquartile range, 474-1952 days). Twenty-six (83.9%) patients underwent surgical treatment with or without neoadjuvant chemotherapy. On MRI, greater tumor size (>3 cm), diverticular neck involvement, perivesical extension, and suspicious lymph nodes were associated with lower overall survival (HR = 3.6-8.1 and 4.3-6.3 for the 2 radiologists, p ≤ 0.03). Other clinicopathological or MRI findings were not associated with survival (p = 0.27-0.65). Inter-reader agreement was excellent for tumor size (ICC = 0.991; 95% CI 0.982-0.996), fair for VI-RADS (K = 0.52, 95% CI, 0.22-0.82), and moderate for others (K = 0.61-0.79). CONCLUSION: In patients with IDBT, several MRI features were significantly associated with overall survival. Utilizing all available clinicopathological and imaging information may improve estimation of prognosis.
Authors: L Cheng; A L Weaver; B C Leibovich; D M Ramnani; R M Neumann; B G Scherer; A Nehra; H Zincke; D G Bostwick Journal: Cancer Date: 2000-05-15 Impact factor: 6.860
Authors: Kaiyumars Contractor; Amarnath Challapalli; Tara Barwick; Mathias Winkler; Giles Hellawell; Steve Hazell; Giampaolo Tomasi; Adil Al-Nahhas; Paola Mapelli; Laura M Kenny; Paul Tadrous; R Charles Coombes; Eric O Aboagye; Stephen Mangar Journal: Clin Cancer Res Date: 2011-10-28 Impact factor: 12.531
Authors: Toni K Choueiri; Susanna Jacobus; Joaquim Bellmunt; Angela Qu; Leonard J Appleman; Christopher Tretter; Glenn J Bubley; Edward C Stack; Sabina Signoretti; Meghara Walsh; Graeme Steele; Michelle Hirsch; Christopher J Sweeney; Mary-Ellen Taplin; Adam S Kibel; Katherine M Krajewski; Philip W Kantoff; Robert W Ross; Jonathan E Rosenberg Journal: J Clin Oncol Date: 2014-05-12 Impact factor: 44.544
Authors: Mohamad Syafeeq Faeez Md Noh; Ahmad Fuad Abdul Aziz; Khairul Asri Mohd Ghani; Christopher Lee Kheng Siang; Rosna Yunus; Mubarak Mohd Yusof Journal: Am J Case Rep Date: 2017-03-01